10 November 2016 : Clinical Research
Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based on the Treatment of Forty-Four Patients
Przemysław PuzABCDEF, Anetta Lasek-BalADFDOI: 10.12659/MSM.898270
Med Sci Monit 2016; 22:4277-4282
HTML version available soon